Th17 cells play a critical role in the development of experimental Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 74, Issue 6, 2015, Pages 1302-1310

  Lin, Xiang ^a   Rui, Ke ^b   Deng, Jun ^a   Tian, Jie ^b   Wang, Xiaohui ^a   Wang, Shengjun ^b   Ko, King Hung ^a   Jiao, Zhijun ^c   Chan, Vera Sau Fong ^d   Lau, Chak Sing ^d   Cao, Xuetao ^e   Lu, Liwei ^a,b   Kvien, Tore K ^f  

^a UNIVERSITY OF HONG KONG   (China)

^b JIANGSU UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; AUTOANTIBODY; IL17A PROTEIN, MOUSE; SALIVA PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE MICROSCOPY; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVARY GLAND; SALIVATION; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND; SYMPTOMATOLOGY; TH17 CELL; ANIMAL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPH NODE; NECK;

ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; IMMUNIZATION; INTERLEUKIN-17; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NECK; SALIVARY PROTEINS AND PEPTIDES; SJOGREN'S SYNDROME; TH17 CELLS;

EID: 84934998034     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204584     Document Type: Article

References (50)

1. Fox RI. Sjögren's syndrome. Lancet 2005; 366:321-31.
2. Peri Y, Agmon-Levin N, Theodor E., et al. Sjögren's syndrome, the old and the new. Best Pract Res Clin Rheumatol 2012; 26:105-17.
3. Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjögren's syndrome. Nat Rev Rheumatol 2013; 9:544-56.
4. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun 2010; 34:400-7.
5. Cardell BS, Gurling KJ. Observations on the pathology of Sjögren's syndrome. J Pathol Bacteriol 1954; 68:137-46.
6. Ahmad Y, Shahril NS, Hussein H, et al. Case review of sarcoidosis resembling Sjögren's syndrome. J Clin Med Res 2010; 2:284-8.
7. van Blokland SC, Wierenga-Wolf AF, van Helden-Meeuwsen CG, et al. Professional antigen presenting cells in minor salivary glands in Sjögren's syndrome: potential contribution to the histopathological diagnosis? Lab Invest 2000; 80:1935-41.
8. Adamson TC III, Fox RI, Frisman DM, et al. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 1983; 130:203-8.
9. Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003; 48:3187-201.
10. Katsifis GE, Moutsopoulos NM, Wahl SM. T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 2007; 32:252-64.
11. Fava RA, Kennedy SM, Wood S.G., et al. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome. Arthritis Res Ther 2011; 13:R182.
12. Youinou P, Pers JO. Disturbance of cytokine networks in Sjögren's syndrome. Arthritis Res Ther 2011; 13:227.
13. Brayer JB, Cha S, Nagashima H., et al. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome. Scand J Immunol 2001; 54:133-40.
14. Cha S, Brayer J, Gao J., et al. A dual role for interferon-gamma in the pathogenesis of Sjögren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand J Immunol 2004; 60:552-65.
15. Katsifis GE, Rekka S, Moutsopoulos N.M., et al. Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol 2009; 175:1167-77.
16. Nguyen CQ, Yin H, Lee B.H., et al. Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther 2010; 12:R220.
17. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8:337-48.
18. Maddur MS, Miossec P, Kaveri S.V., et al. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012; 181:8-18.
19. Lai Kwan Lam Q, King Hung Ko O, Zheng BJ, et al. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA 2008; 105:14993-8.
20. Wen Z, Xu L, Xu W., et al. Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA. PLoS ONE 2013; 8:e58161.
21. Sakai A, Sugawara Y, Kuroishi T., et al. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of L-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 2008; 181:2898-906.
22. Karabiyik A, Peck AB, Nguyen CQ. The important role of T cells and receptor expression in Sjögren's syndrome. Scand J Immunol 2013; 78:157-66.
23. Lin X, Song JX, Shaw P.C., et al. An autoimmunized mouse model recapitulates key features in the pathogenesis of Sjögren's syndrome. Int Immunol 2011; 23:613-24.
24. Hunger RE, Carnaud C, Vogt I., et al. Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. J Clin Invest 1998; 101:1300-9.
25. Iizuka M, Wakamatsu E, Tsuboi H., et al. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis. J Autoimmun 2010; 35:383-9.
26. Scardina GA, Spano G, Carini F., et al. Diagnostic evaluation of serial sections of labial salivary gland biopsies in Sjögren's syndrome. Med Oral Patol Oral Cir Bucal 2007; 12:E565-8.
27. Ben-Sasson SA, Sherman Y, Gavrieli Y. Identification of dying cells-in situ staining. Methods Cell Biol 1995; 46:29-39.
28. Richard A, FlavellYang M, Deng J., et al. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol 2012; 180:2375-85.
29. Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos H.M., et al. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum 2005; 52:1517-21.
30. Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol 2010; 6:529-37.
31. Tsuboi H, Matsumoto I, Wakamatsu E., et al. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome. Clin Exp Immunol 2010; 162:53-61.
32. Dawson LJ, Stanbury J, Venn N., et al. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 2006; 54:1165-73.
33. Hagiwara E, Pando J, Ishigatsubo Y., et al. Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J Rheumatol 1998; 25:89-93.
34. Kolkowski EC, Reth P, Pelusa F., et al. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome. J Autoimmun 1999; 13:155-62.
35. Szodoray P, Alex P, Brun J.G., et al. Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system. Scand J Immunol 2004; 59:592-9.
36. Szodoray P, Alex P, Jonsson M.V., et al. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol 2005; 117:168-76.
37. Pers JO, Lahiri A, Tobon G.J., et al. Pathophysiological cytokine network in primary Sjögren's syndrome. Presse Med 2012; 41:e467-74.
38. Feng T, Qin H, Wang L., et al. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. J Immunol 2011; 186:6313-18.
39. Nguyen CQ, Hu MH, Li Y, et al. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice. Arthritis Rheum 2008; 58:734-43.
40. Sudzius G, Mieliauskaite D, Butrimiene I., et al. Activity of T-helper cells in patients with primary Sjögren's syndrome. In Vivo 2013; 27:263-8.
41. Jacobs JP, Wu HJ, Benoist C, et al. IL-17-producing T cells can augment autoantibody-induced arthritis. Proc Natl Acad Sci USA 2009; 106:21789-94.
42. Barbosa RR, Silva SP, Silva S.L., et al. Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation. PLoS ONE 2011; 6:e22848.
43. Groom J, Kalled SL, Cutler A.H., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002; 109:59-68.
44. Daridon C, Devauchelle V, Hutin P., et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2007; 56:1134-44.
45. Lavie F, Miceli-Richard C, Ittah M., et al. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Scand J Immunol 2008; 67:185-92.
46. Candon S, Gottenberg JE, Bengoufa D, et al. Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity. Ann Rheum Dis 2009; 68:1208-12.
47. Deng J, Liu Y, Yang M., et al. Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum 2012; 64:3564-73.
48. Ittah M, Miceli-Richard C, Eric Gottenberg J, et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Res Ther 2006; 8:R51.
49. Towne JE, Krane CM, Bachurski C.J., et al. Tumor necrosis factor-alpha inhibits aquaporin 5 expression in mouse lung epithelial cells. J Biol Chem 2001; 276:18657-64.
50. Vogelsang P, Jonsson MV, Dalvin S.T., et al. Role of dendritic cells in Sjögren's syndrome. Scand J Immunol 2006; 64:219-26.